Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against Naegleria fowleri

Pathogens(2020)10.3390/pathogens9090689Source: DataRank Database

In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against Naegleria fowleri is a research paper published in Pathogens (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.67)OA: goldTopics (24)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Anjan Debnath ORCID,Hye Jee Hahn ORCID

Live enrichment

PubMed:32842691 PMC:PMC7560193 OpenAlex:https://openalex.org/W3080408192

National Institutes of Health

Grant: 1KL2TR001444, 1R21AI146460

NIAID NIH HHS

Grant: R21 AI146460

NCATS NIH HHS

Grant: KL2 TR001444

FWCI

0.67

Citation Percentile

0.7%

Citation Trend

2021

2024

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/2076-0817/9/9/689/pdf?version=1598093577

publisherhttps://www.mdpi.com/2076-0817/9/9/689/pdf?version=1598093577

publisherhttps://www.mdpi.com/2076-0817/9/9/689/pdf

journalhttps://doi.org/10.3390/pathogens9090689

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32842691

Fields of Study

Legionella and Acanthamoeba researchAmoebic Infections and TreatmentsHeme Oxygenase-1 and Carbon Monoxide

Keywords

PitavastatinNaegleria fowleriFarnesyltransferase inhibitorFarnesyltransferaseMevalonate pathwayPharmacologyBiologyHMG-CoA reductaseReductaseFarnesyl-diphosphate farnesyltransferaseAmphotericin BMicrobiologyEnzymeBiochemistryPrenylationImmunologyMeningoencephalitis3-Hydroxy-3-methyl-glutaryl-coa ReductaseLonafarnibFree-living AmoebaPrimary Amoebic Meningoencephalitis

Sustainable Development Goals

SDG 0: Good health and well-being